🔴 Nasus Pharma is trading 6.25% down with no confirmed catalyst

Nasus Pharma is trading at $3.00, down 6.25%, with no confirmed catalyst for the November 4 decline.

• No company-specific announcement explaining the November 4 decline surfaced in available news listings.
• Recent analyst coverage and price-target changes predate this session. The broader market and healthcare sector are rising, so they do not align with or explain the drop.
• The November 3 report also noted no specific announcement explaining that session’s move.